Toggle Main Menu Toggle Search

Open Access padlockePrints

A Slc5a6-Deficient Mouse Model Reveals Metabolically Driven Cardiomyopathy with Therapeutic Potential for Vitamin-Based Intervention

Lookup NU author(s): Dr Millie FullertonORCiD, Lauren Charlotte Phillips Phillips, Dr Rachael RedgraveORCiD, Dr Luke Spray, George MercesORCiD, Scott Kerridge, Professor Gavin RichardsonORCiD, Becky Crossley, Dr Simon BamforthORCiD, Dr Helen PhillipsORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

The sodium-dependent multivitamin transporter, encoded by SLC5A6, mediates cellular uptake of biotin and pantothenic acid, essential cofactors for energy metabolism. We identified two families with SLC5A6 mutations presenting with early-onset dilated cardiomyopathy (DCM). To investigate the link between vitamin deficiency and cardiomyopathy, we generated a cardiac-specific SLC5A6 knockout (Slc5a6cKO) mouse model and evaluated the impact of vitamin supplementation. Slc5a6cKO mice developed progressive cardiac dysfunction, culminating in cardiac pathology and premature death at 26 weeks; earlier stages exhibited cardiomyocyte hypertrophy, fibrosis, impaired Coenzyme A synthesis, and metabolic imbalance, indicating progression toward cardiomyopathy. Cardiac magnetic resonance imaging and ECG confirmed progressive functional decline. Proteomic analysis revealed early mitochondrial metabolic disruption and extracellular matrix protein upregulation at 8 weeks, preceding overt cardiac dysfunction. Strikingly, vitamin supplementation from preconception onwards prevented the cardiac phenotype, preserving cardiac structure, function, morphology and survival. This paralleled the clinical outcome in one patient who received early vitamin treatment, compared to another who required a heart transplant without vitamin treatment. This study establishes a direct link between SLC5A6-mediated vitamin transport, mitochondrial function, and cardiac health. It highlights how vitamin deficiency contributes to cardiomyopathy pathogenesis and supports early vitamin supplementation as a potential therapeutic strategy for metabolic cardiomyopathies.


Publication metadata

Author(s): Fullerton MO, Phillips LC, Redgrave RE, Spray L, Haufroid V, Merces G, Kerridge ST, Richardson GD, Mercier N, Roland D, Crossley R, Morgan ADH, Dewulf JP, Burn J, Bamforth SD, Phillips HM

Publication type: Article

Publication status: Published

Journal: JCI Insight

Year: 2026

Pages: epub ahead of print

Online publication date: 02/06/2026

Acceptance date: 21/05/2026

Date deposited: 03/06/2026

ISSN (electronic): 2379-3708

Publisher: American Society for Clinical Investigation

URL: https://doi.org/10.1172/jci.insight.200381

DOI: 10.1172/jci.insight.200381


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
British Heart Foundation (grant numbers PG/16/105/32659 and PG/24/11744)

Share